ISSN Print: 2381-1420  ISSN Online: 2381-1447
AASCIT Journal of Medicine  
Manuscript Information
 
 
Application of the Neuromatrix Pain Theory to Understand Sex and Gender Differences in Chronic Pain
AASCIT Journal of Medicine
Vol.1 , No. 5, Publication Date: Dec. 11, 2015, Page: 67-73
3600 Views Since December 11, 2015, 1655 Downloads Since Dec. 11, 2015
 
 
Authors
 
[1]    

Mona H. Mathna, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Menoufia University, Egypt.

[2]    

Joy C. MacDermid, Department of Physical Therapy, University of Western Ontario, London, ON.

 
Abstract
 

Since chronic pain is a complex phenomenon, a conceptual model may be useful in understanding this complexity. One conceptual model commonly used to explain chronic pain is the neuromatrix pain theory, which aims to explain the integrative role of the brain in pain generation. While this model does not specifically identify aspects of sex and gender that might affect pain; it may lend itself to this application. The objective of this paper is to explore the influence of gender and sex in the context of the neuromatrix theory for better understanding of the widely reported gender/sex difference in chronic pain experience. Understanding the difference between the meaning of gender and sex is essential, because this can help identifying and organizing the role of both gender and sex as different inputs to the neuromatrix. Sex refers to the biologic condition of an individual as being female versus male, while gender refers to the social role with which an individual identifies. Gender can influence the cognitive and affective components of pain. So, gender can be considered as cognitive and/or affective inputs to the neuromatrix, which can modulate the pain neurosignature within the neuromatrix and consequently influences pain responses. However, sex hormones play a vital role in production of sex difference in pain response. Estrogen can influence pain processing before the level of the neuromatrix resulting in change in the sensory signaling input to the neuromatrix. It can also influence the different anatomical constitutes of the neuromatrix. Another contributing finding that can help explaining the sex difference and also the individual variations among women in pain response is the genetic expression of estrogen receptors within the neuromatrix. Eventually, it seems that there are multiple inter-related factors that may interact to modulate the pain neurosignature within the neuromatrix and produce the gender/sex difference in pain response. Considering these factors can guide pain management in women, and can also identify sex/gender as predictors of chronic pain that may become future treatment targets.


Keywords
 

Neuromatrix Pain Theory, Pain, Sex, Gender


Reference
 
[01]    

Melzack, R. (2005) Evolution of the neuromatrix theory of pain. The Prithvi Raj Lecture: presented at the third World Congress of World Institute of Pain, Barcelona 2004. Pain Pract., 5, 85–94.

[02]    

Goldberg, D.S., & McGee, S.J. (2011). Pain as a global public health priority. BMC Public Health, 11,770.

[03]    

Melzack, R. (2008). The Future of Pain. Editorial, Nature Reviews Drug Discovery, 7, 629.

[04]    

International Pain Summit of the International Association for the Study of Pain. (2011). Declaration of Montréal: declaration that access to pain management is a fundamental human right. J Pain Palliat Care Pharmacoth, 25(1), 29-31.

[05]    

Debono, D.J., Hoeksema, L.J., & Hobbs, R.D. (2013). Caring for Patients with Chronic Pain: Pearls and Pitfalls. Journal of the American Osteopathic Association, 113 (8), 620–627.

[06]    

Turk, D.C., & Okifuji, A. (2001). "Pain terms and taxonomies". In Loeser, D., Butler, S. H., Chapman, J. J. et al. Bonica's management of pain (3 ed.). Lippincott Williams & Wilkins, 18–25.

[07]    

LeResche, L. (1997). Epidemiology of temporomandibular disorders: implications for the investigation of etiologic factors. Crit Rev Oral Biol Med, 8:291–305.

[08]    

Lipton, R.B., & Stewart, W.F. (1998). Migraine headaches: epidemiology and comorbidity. Clin Neurosci, 5:2–9.

[09]    

Mayer, E.A., Naliboff, B., Lee, O., Munakata, J., & Chang L. (1999). Review article: gender related differences in functional gastrointestinal disorders. Aliment Pharmacol Ther, 13(2), 65–69.

[10]    

Wolfe, F., Ross, K., Anderson, J., Russell, I.J., & Hebert, L. (1995). The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheumatol,, 38,19–28.

[11]    

Dao, T.T.T. & LeResche, L. (2000). Gender differences in pain. J Orofac Pain, 14 , 169–184.

[12]    

Fillingim, R.B. (2000). Sex, gender, and pain: Women and men really are different. Current Review of Pain, 4 (1), 24-30.

[13]    

Greenspan, J.D., Craft, R.M., LeResche, L., Arendt-Nielsen, L., Berkley, K.J., Fillingim, ......Traub, R.J. (2007). Studying sex and gender differences in pain and analgesia: A consensus report. Pain, 132, S26–S45.

[14]    

Melzack, R. (1990). Phantom limbs and the concept of a neuromatrix. Trends Neurosci, 13, 88–92.

[15]    

Melzack, R. (2001). Pain and the neuromatrix in the brain. J Dent Educ, 65, 1378-82.

[16]    

Moseley, G.L., & Flor, H. (2012). Targeting Cortical Representations in the Treatment of Chronic Pain: A review. Neurorehabil Neural Repair, 26, 646- 652.

[17]    

Myers CD, Riley JL III, & Robinson ME. (2003). Psychosocial contributions to sex-correlated differences in pain. Clin J Pain, 19, 225-32.

[18]    

Robinson, M.E., & Riley, J.L.I. (1999). The role of emotion in pain, in Gatchel RJ, Turk DC (eds): Psychosocial Factors in Pain. New York, Guilford Press, 74-88.

[19]    

Edwards RR, Haythornthwaite JA, Sullivan MJ, & Fillingim RB. (2004). Catastrophizing as a mediator of sex differences in pain: Differential effects for daily pain versus laboratory-induced pain. Pain, 111,335-341.

[20]    

Fillingim RB, Wilkinson CS, Powell T. (1999). Self-reported abuse history and pain complaints among healthy young adults. Clin J Pain, 15, 85-91.

[21]    

Osman, A., Barrios, F.X., Gutierrez, P.M., Kopper, B.A., Merrifield, T., & Grittmann L. (2000). The Pain Catastrophizing Scale: Further psychometric evaluation with adult samples. J Behav Med 23:351-365.

[22]    

Lynch, A.M., Kashikar-Zuck, S., Goldschneider, K.R., & Jones BA. (2007). Sex and age differences in coping styles among children with chronic pain. J Pain Symptom Manage, 33, 208-216.

[23]    

Fillingim RB. (2005). Individual differences in pain responses. CurrRheumatol Rep.,7, 342–7.

[24]    

Scher AI, Stewart WF, Liberman J, Lipton RB. (1998). Prevalence of frequent headache in a population sample. Headache, 38, 497–506.

[25]    

Lee C, Powers JR. (2002). Number of social roles, health, and well-being in three generations of Australian women. Int J Behav Med, 9:195–215.

[26]    

Bekker MH, & Van Mens-Verhulst J. (2007). Anxiety disorders: Sex differences in prevalence, degree, and background, but gender-neutral treatment. Gend Med, 4 (Suppl B): S178-S193.

[27]    

Rhudy, J.L., Williams, A.E. (2005). Gender differences in pain: Do emotions play a role? Gend Med, 2, 208-226.

[28]    

Rollman GB: (1995). Gender differences in pain: Role of anxiety.Pain Forum, 4, 231-234.

[29]    

Munce SE, & Stewart DE. (2007). Gender differences in depression and chronic pain conditions in a national epidemiologic survey. Psychosomatics 48,394-399.

[30]    

Marcus, S.M., Kerber, K.B., Rush, A.J., Wisniewski, S.R., Nierenberg, A., Balasubramani, G.K., ...., Trivedi MH. (2008). Sex differences in depression symptoms in treatment-seeking adults: Confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study. Compr Psychiatry, 49: 238-246.

[31]    

Moseley, G.L. (2007). Reconceptualising Pain According To Modern Pain Science. Physical Therapy Reviews, 12, 169–178.

[32]    

LeResche, L. (2000). Epidemiologic perspectives on sex differences in pain. In: Fillingim RB, ed. Sex, Gender and Pain: Progress in Pain Research and Management. Vol 17. Seattle, WA: IASP Press; 2000: 233–249.

[33]    

Bennett R. (2003). Fibromyalgia. In: Melzack R, Wall PD, eds. Handbook of Pain Management. Edinburgh: Churchill Livingstone, 95–108.

[34]    

Clauw, D. J. (2014). Fibromyalgia. JAMA, 311 (15), 1547.

[35]    

Bartels, E.M., Dreyer, L., Jacobsen, S., Jespersen, A., Bliddal, H., & Danneskiold-Samsoe, B. (2009). Fibromyalgia, diagnosis and prevalence. Are gender differences explainable? Ugeskr Laeger, 171 (49), 3588–92.

[36]    

Marcus, D.A. (1995). Interrelationships of neurochemicals, estrogen, and recurring headache. Pain, 62, 129–139.

[37]    

Aloisi, A.M., & Ceccarelli, I. (2000). Role of gonadal hormones in formalin- induced pain responses of male rats: Modulation by estradiol and naloxone administration. Neuroscience, 95, 559–566.

[38]    

Aloisi, A.M. (2003). Gonadal hormones and sex differences in pain reactivity. Clin J Pain, 19, 168–74.

[39]    

Aloisi A.M., & Bonifazi M. (2006). Sex hormones, central nervous system and pain. Hormones and Behavior, 50 (1), 1–7.

[40]    

Craft, R.M. (2003). Sex differences in opioid analgesia: from mouse to man. Clin J Pain, 19,175–86.

[41]    

Craft R.M., Mogil, J.S., & Aloisi, A.M. (2004). Sex differences in pain and analgesia: the role of Gonadal hormones. European Journal of Pain, 8 (5), 397–411.

[42]    

Kaergaard, A., Hansen, A.M., Rasmussen, K., & Andersen, J.H. (2000). Association between plasma testosterone and work-related neck and shoulder disorders among female workers. Scand. J. Work Environ. & Health, 26, 292–298.

[43]    

English, K.M., Steeds, R.P., Jones, T.H., Diver, M.J., & Channer, K.S. (2000). Low dose Transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation, 102, 1906–1911.

[44]    

Carlton, S.M., McNearney, T.A & Cairns, B.E. (2003). Peripheral glutamate receptors: Novel targets for analgesics? In J.O. Dostrovsky, D.B. Carr and M. Koltzenburg (Eds.), Proceedings of the 10th World Congress on Pain, Vol. 24, IASP Press, Seattle, pp. 125-139.

[45]    

Milam, S.B., Aufdemorte, T.B., Sheridan, P.J., Triplett, R.G., Van Sickels, J.E. & Holt, G.R. (1987). Sexual dimorphism in the distribution of estrogen receptors in the tempoman-dibular joint complex of the baboon., Oral Surg Oral Med Oral Pathol Oral Radiol Endo, 64, 527-532.

[46]    

Cairns, B.E., Wang, K., Hu, J.W., Sessle, B.J., Arendt-Nielsen, L. & Svensson, P. (2003). The effect of glutamate-evoked masseter muscle pain on the human jaw-stretch re-flex differs in men and women, J Orofacial Pain, 17, 317-325.

[47]    

McRoberts, J.A., Li, J., Ennes, H.S., & Mayer, E.A. (2007). Sex-dependent differences in the activity and modulation of N-methyld-aspartic acid receptors in rat dorsal root ganglia neurons. Neuroscience, 21(148), 1015-1020.

[48]    

Lomas, L.M., Terner, J.M., & Picker, M.J. (2008). Sex differences in NMDA antagonist enhancement of morphine antihyperalgesia in a capsaicin model of persistent pain: Comparisons to two models of acute pain. Pharmacol Biochem Behav, 89: 127-136.

[49]    

Woolley, C.S., Schwartzkroin, P.A. (1998). Hormonal effects on the brain. Epilepsia 39, S2–S8.

[50]    

Murphy, D.D., Cole, N.B., Greenberger, V., & Segal, M. (1998). Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 18, 2550–2559.

[51]    

Beyenburg, S., Stoffel-Wagner, B., Bauer, J., Watzka, M., Blumcke, I., Bidlingmaier, F., & Elger, C.E., 2001. Neuroactive steroids and seizure susceptibility. Epilepsy Res. 44, 141–153.

[52]    

Smith, M.D., Jones, L.S., Wilson, M.A. (2002a). Sex differences in hippocampal slice excitability: role of testosterone. Neuroscience, 109, 517–530.

[53]    

McEwen, B.S., & Alves, S.E. (1999). Estrogen actions in the central nervous system. Endocr. Rev. 20, 279–307.

[54]    

Suzuki, S., & Handa, R.J. (2005). Estrogen receptor-beta, but not estrogen receptor alpha, is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: comparison with other neuropeptides. J Comp Neurol, 484, 28–42.

[55]    

Gonza´ lez, M., Cabrera-Socorro, A., Pe´rez-García, C.G., Fraser, J.D., Lo´pez, F.J., Alonso, R., & Meyer, G. (2007). Distribution patterns of estrogen receptor alpha and beta in the human cortex and hippocampus during development and adulthood. J Comp Neurol, 503,790–802.

[56]    

Tetel, M.J. (2009). Nuclear receptor coactivators: essential players for steroid hormone action in the brain and in behaviour. J Neuroendocrinol, 21, 229–237.

[57]    

Fillingim RB, Ness TJ. (2000). Sex-related hormonal influences on pain and analgesic responses. Neurosci Biobehav Rev 24, 485-501.

[58]    

Zubieta, J.K., Smith, Y.R., Bueller, J.A., Xu, Y., Kilbourn, M.R., Jewett, D.M., .. Stohler, C.S. (2002). Mu-opioid receptor- mediated antinociceptive responses differ in men and women. J Neurosci 22, 5100-5107.

[59]    

McEwen BS. (2001). Invited review: Estrogens effects on the brain: Multiple sites and molecular mechanisms. J Appl Physiol 91, 2785-2801.

[60]    

Vamvakopoulos, N.C., & Chrousos, G.P. (1993). T6/Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J. Clin. Invest., 92, 1896–1902.

[61]    

Saunders, P.T., Maguire, S.M., Gaughan, J., Millar, M.R. (1997). Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry. J. Endocrinol. 154, R13–R16.

[62]    

Adler, G.K., Kinsley, B.T., Hurwitz, S., Mossey, C.J., & Goldenberg, D.L. (1999). Reduced hypothalamic–pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am. J. Med. 106,534–543.

[63]    

Riva R., Mork, P.J., Westgaard, R.H., Ro, M., & Lundberg, U. (2010). Fibromyalgia syndrome is associated with hypocortisolism. Int J Behav Med., 17(3), 223-33.

[64]    

Aloisi, A.M., Pari, G., Ceccarelli, I., Vecchi, I., Ietta, F., Lodi, L., Paulesu, L. (2005). Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain 115, 142–151.





 
  Join Us
 
  Join as Reviewer
 
  Join Editorial Board
 
share:
 
 
Submission
 
 
Membership